I. Radioimmunoassay has been used to detect and estimate the urinary excretion of deoxycorticosterone (DOC) in normal, hypertensive and hypokalaemic subjects. The range of excretions in ten healthy normal subjects was 41-232 pmol (13'7-76'7 ng) daily, with a mean of 124 pmol (41 ng).
Introduction
In 1962 Cope, Harwood & Pearson noted that aldosterone secretion was low in some cases of essential hypertension, and suggested the possible presence of an aldosterone-inhibiting factor as cause. Soon afterwards Brown, Davies, Lever & Robertson (1964) observed that plasma renin activity was also abnormally low in some cases of apparent essential hypertension, a fact suggesting that an inhibitory factor was acting on the renin-angiotensin system.
These cases of hypertension with low plasma renin activity and aldosterone secretion have attracted increasing interest in recent years. A probable cause for the inhibition of both renin and aldosterone production is the formation in such patients of an alternative mineralocorticoid. Melby, Dale, Grekin, Gaunt & Wilson (1972) have suggested that 18-hydroxydeoxycorticosterone may be the steroid responsible in some subjects.
Another possible mineralocorticoid is deoxycorticosterone (DOC). The behaviour of this potent and naturally occurring steroid has thus become of considerable interest, and this has been enhanced by the finding by Brown, Ferriss, Fraser, Lever, Love, Robertson & Wilson (1972) of raised plasma concentrations of DOC in essential hypertensive patients showing a tendency to hypokalaemia.
Deoxycorticosterone (DOC) has hitherto been a difficult steroid hormone to study in man. The extensive studies of Biglieri, Slaton, Schambelan & Kronfield (1968) , and of other workers on DOC production rates, have required a laborious and exacting extraction and purification of a unique metabolite in urine, tetrahydrodeoxycorticosterone (TH-DOC). DOC itself is generally regarded as absent from normal urine, and as only appearing in rare cases of adrenal disease. Brown & Strott (1971) , using a relatively sensitive competitive protein-binding method, could detect DOC in plasma in only 40~"~of normal persons, and they considered the concentration to be below 152 pmol/l (5 ng/IOO ml) in the remainder. Oddie, Coghlan & Scoggins (1972) , used an exacting doubleisotope derivative method and found the mean normal plasma DOC concentration to be 191 prnol/l (6'3 ng/loo ml). Brown et al. (1972) used a gas-liquid chromatography method with electron capture developed by Wilson & Fraser (1971) for their assay of plasma DOC mentioned above.
The development by Arnold & James (1971) of a potent antiserum relatively specific for DOC makes possible considerable simplification of the assay of DOC in biological fluids. Arnold & James (1971) have applied the antiserum to the assay of plasma DOe. The present work reports the application of this antiserum to the assay of urinary DOC excretion in normal, hypertensive and hypokalaemic subjects. Several instances of elevated DOC excretion have thereby been revealed.
Methods

Materials
Deoxycorticosterone (4-pregnen-21-01-3,20-dione) was obtained from Koch-Light Laboratories Ltd.
[1,2-3 H1Deoxycorticosterone was obtained from New England Nuclear Corp. Stated activity was 45 Ci/rnmol. It was diluted with benzene-ethanol (9: I, v/v) to a concentration of 5 pCi/ml and stored at 4e. It was checked for purity at intervals by chromatography with excess of carrier DOC on the Bush (1952) B3 system. Average purity was 97~:,.
Anti-deoxycorticosterone serum, prepared from rabbits by the method of Arnold & James (1971) from a 3-oxime conjugate, was received from Professor V. H. T. James as a generous gift. This antiserum was first diluted I in 50 with 0·1 mol/l borate buffer, pH g·O, containing 5 g/I of crystalline bovine serum albumin (Armour), and was stored at -20°C in 0·5 ml aliquots. When required these were diluted a further 50 times with the same albumin-containing buffer and were dispensed in 0·5 ml of a 1: 2500 dilution. These were also stored at -zo-c.
Organic solvents were AnalaR grade. When used in chromatography tanks they were not redistilled. Benzene and ethyl acetate used as solvents were redistilled before use. Ethanol (RR) was purified by refluxing with sodium hydroxide and silver nitrate before final redistillation through a Vigreux column. All dichloromethane was redistilled, and was freshly washed twice with an equal volume of water immediately before use.
Extraction offree deoxycorticosterone from urine
Urine collections were acidified with acetic acid (5 ml/I) and deep-frozen until required for analysis.
A volume of urine equivalent to 1 h excretion, i.e.
•', of a 24 h collection, was extracted with two successive equal volumes of freshly washed dichloromethane after the addition of about 1200 d.p.s. of [1,2-3H1DOe. The extract was then centrifuged, if necessary, to free it of emulsion, and washed twice with -+ vol. of 0·1 mol/l sodium hydroxide, once with -+ vol. of 0·1 mol/l acetic acid and once with -+ vol. of distilled water. The washed extract was dried by passage through anhydrous sodium sulphate and evaporated to dryness on a water bath at 50°C with mild suction to speed the distillation. The residue was dissolved in 4 ml of benzeneethanol (9: 1, v/v), transferred to a small conical tube and evaporated to a volume of about 100 pi in a stream of air. This concentrate was transferred to the starting line of a Whatman no. I chromatography paper and run for 4-5 h in the Bush (1952) B3 system after overnight equilibration. Sudan Red and Blue F II dye (Ciba) were run as markers in adjacent lanes. After development and subsequent drying, the area from a point level with the centre of the F II spot to 3·5 cm below this was cut out and eluted into benzene-ethanol (9: I, vlv). This eluate was concentrated and reapplied to a second paper chromatogram. This was equilibrated for 5 h in the Bush (1952) A system, and was then run for 15-17 h (overnight), the lower edge of the paper being serrated to allow effective run-off of the mobile phase. F II dye was again used as a marker; this runs about 15 em in 16 h. The area from a point level with the centre of the F II spot to 3·5 em above this was cut out and eluted into 4 ml of benzeneethanol (9: 1, v/v). A portion (0,5 ml) of this eluate was taken into a phial for radioactivity counting for tritium recovery, and the remainder was available for assay. In the E4 system of Eberlein & Bongiovanni (1955) DOC runs at 125% of the rate of F II dye.
Assay procedure
The main details of technique of radioimmunoassay for DOC are essentially those described for aldosterone by Cope & Loizou (1973) . Modifications have been made to adapt this to the DOC assay. Two reagents are prepared before each assay run:
(1) sufficient of the 1: 2500 antiserum for the run is diluted a further 20 times with 0'1 mol/I borate buffer pH 8,0, containing 5 gil albumin, to give a finai dilution of 1: 50 ()()(); (2) Tubes for standard curves contained 0, 0'15, 0,3, 0'6, 1·5 and 3·0 pmol (0'05, 0'1, 0'2, 0·5 and 1·0 ng) of DOC. All dilutions were made with benzeneethanol (9: 1, vIv). Samples for assay require 1'0 ml or less per tube, the total volume of each tube being made up to 1 ml. 0·2 ml of the diluted [1,2-3H]DOC was added to each tube before evaporation to dryness in a gentle air stream. When dry, 0·5 ml of the diluted antiserum was added and well mixed. After incubation overnight at 4DC, separation of bound from free fractions was made by use of dextran-coated charcoal (25 mg of each per 10 rnl), the whole being maintained at ODC in an ice bath throughout. All unknowns were assayed at two or more different concentrations and in duplicate at each.
Eluates for tritium counting were evaporated to dryness before solution in Kinard's (1957) scintillator solution. Supernatants of assay tubes were dissolved in 20 vol. of Kinard's solution for radioactivity counting. Radioactivity counting was in either a Packard Tricarb model 314 or an Intertechnique model SL 36; counting efficiency was about 35%, and counting was continued long enough to achieve 1% accuracy for each sample.
Calculation
The sample tubes are not strictly comparable with the standard curve tubes because the former contain a quantity of additional [1,2-3H]DOC derived from the internal standard. The amount of this will vary both with the efficiency of recovery through the purification stages and with the degree of dilution of the unknown eluate needed for the assay. The bound tritium in the unknowns has therefore been expressed as a percentage of the total [3H]DOC present in each tube, the extra quantity added being calculated from the tritium content of the eluate, which has already been measured to determine the recovery of the internal standard. The presence of this extra tritium tends to depress the standard curve, the effect being greater with amounts below 450 fmol (150 pg) than above this value. In the range 45Q.....900 fmol, where the great majority of our unknowns have been read, the error introduced from this cause has been found to be between 2 and 4 % only. The additional DOC introduced in this internal standard is subtracted from the calculated content. It was usually 545 fmol (180 pg)/l h urine sample.
Results
Assay tests
Standard curve. With the quantities ofreagents used. The percentage of tritium bound in the unknown tube is compared with the binding of the standard curve, and the equivalent amount of DOC is read off from this curve. the assay curve has given a mean of 45 /;; of bound tritium in the zero tube, with a fall to 7·55/;; in the 3 pmol tube. The standard deviation of all curves done over a period of 7 months was 1·59 in the zero tube, and 0·53 for the 3 pmol tube. Values of SD for intermediate values are indicated in Fig. I . The coefficient of variation of replicate estimations at the zero point was 2·28/;; (11=20). Sensitivity. On the assumption that the minimum detectable quantity of DOC per tube is indicated by twice the standard deviation of replicate values at the zero point (SD = 1'12), a quantity of 22 fmol (7 pg) should be just detectable. In practice all assays have been based on quantities in excess of 300 fmol (100 pg) per tube.
Recovery of internal standard. The recovery of [1,2-3H]DOC added to urine as an internal standard has averaged 97/;; in the dichloromethane extract, 59'2°;,±2'9 (n=l1) in the B3 eluate, 40'3/~±6'8 (n = 30) in the Bush (1952) A eluate, and 24 o~in the E4 eluates.
Specificity. Table I shows the results of testing a series of allied steroids against the anti-DOC serum used, in amounts of 1 and 9 pmol. The main ones showing significant cross-reaction with the antiserum are progesterone (12/;;), 18-hydroxycorticosterone (2 /~), testosterone (2/;;) and corticosterone (1'5/;;). All these are effectively removed by the two stages of chromatography. Progesterone is poorly extracted by dichloromethane and runs well in front of DOC in both systems, corticosterone remains near the origin, and 18-hydroxycorticosterone runs at 59/õ f the rate of DOC. Tests with tritium-labelled testosterone have shown that 97 //~or more is removed in the B3 chromatogram. Evidence that any residual testosterone is insignificant is presented below.
Precision. In the course of assay estimations have always been made at two or more concentrations and in duplicate. The coefficient of variation between duplicate tubes was, in the 30-300 fmol range 7'5/;;, from 300 to 1500 fmol 4'0/;;, and from 1500 to 3000 fmol 5·0/;;. The coefficient of variation between assays at two concentrations was 4·2 /;; (11 = 29).
Blank values
When 50 ml samples of water were processed through the whole assay the blank value, after subtraction of the internal standard, was found to vary from 15 to 66 fmol (5-22 pg) per assay tube. This blank value is of complex derivation. One component is a small negative value derived from the paper eluted. This was affected neither by prior washing of the paper nor by the passage of the mobile phase solvent.
But the major component is a true reagent blank, and the largest single contribution to this has been found to be the anhydrous sodium sulphate used to dry the dichloromethane extracts. The lower blank values are given by the higher quality samples, the best being A.R. grade. The interference survives the washing stages, is carried down the chromatogram and appears in the final eluate. The resultant reagent blank is directly additive and is proportional to the amount of eluate used per assay tube.
Its effect on the ultimate estimate of the daily DOC excretion will depend on the volume of urine extracted and on the percentage tritium recovery. With one-quarter of the total eluate assayed per tube the reagent blank has averaged 54 fmol (18 pg) per tube (11 = 10). With a mean recovery of 40/;; in the Bush A eluate this is equivalent to 10·9 pmol (3-6 ng)/1. No additional contribution to this reagent blank value is made by DOC-free human urine. Two urine extracts from a panhypopituitary subject, and two from a fully dexamethasone-suppressed patient, gave values from 8·1 to 11·5 pmol daily (2·7-3'8 ng) with a mean value of 10·3 pmol (3'4 ng) (n =4).
Recovery of added deoxycorticosterone
The presence of the reagent blank value does not interfere with the assay of added DOC. When amounts of 150-600 fmol of DOC were added to reagent blank eluates and assayed, the recovery was 99% ±7 (n= 11). When 3-12 pmol of DOC was added to 2 h samples of urine from a hypopituitary patient the recovery, after processing through the whole extraction procedure and subtraction of internal standard and reagent blank, was, for 3 pmol, 103'5%±5 (n=4), for 6 pmol, 102%±8 (n=6), and for 12 pmol, 105% ± 5·5 (n = 6). Similar recoveries have been made when extra DOC was added to normal urine samples already containing some natural free DOC, the mean recovery being 98% ±5·7 (n=7) ( Table 2) .
Purity Of extracted free deoxycorticosterone
When dichloromethane extracts of normal urine to which [1,2-3H]DOC has been added are washed and then run on the B3 system, a zone is usually found above the true DOC zone which reacts with the anti-DOC serum but does not itself contain tritium. The R F of this substance on B3 is about 87% of that of DOC. This substance often spreads into the DOC zone, causing a contamination which can rise as high as 20%. The nature of this contaminant has not been determined, but its quantity has been estimated by the anti-DOC serum to be a mean of 180 pmol daily in normal urine samples, expressed as DOC equivalent. The amount of this contaminant is not increased in urine samples showing a raised free DOC content, so that the problem of this contamination becomes progressively less as the DOC excretion becomes greater.
A second chromatography on the Bush (1952) A system removes the contaminant, the R F in this system being about 80% of that of DOC. In this respect it differs from testosterone, which runs with DOC in the Bush (1952) A system and would not be separated.
Evidence of adequate purification of the urinary DOC before assay has been obtained by demonstration of constancy of specific radioactivity in successive chromatographies. In a representative series of ten such comparisons, with widely differing DOC contents, the rise in specific radioactivity of B3 eluates after a second chromatography on the Bush (1952) A system averaged 5/;;. That testosterone is not an appreciable contaminant, even in urine samples of low DOC content, has been shown by submitting three such urine extracts, two of which were from young male subjects, to a third stage of chromatography on the E4 system of Eberlein & Bongiovanni (1955) . The mean change in specific radioactivity is only 4/;;, although in this system testosterone runs at nearly twice the rate of DOC and is effectively removed (Table 3 ). All estimates of urinary DOC have been made on eluates obtained after the two stages of chromatography. In the calculations the additional DOC of the internal standard has been subtracted, but the reagent blank value has not been deducted.
Urinary excretion of deoxycorticosterone
Normal free DOC excretion. Ten normal urine samples from healthy subjects gave free DOC excretion rates of from 41 to 232 pmol daily (13'7-76·7 ng), the mean value being 124 pmol (41 ng). If correction is made for the reagent blank value, averaging 10·8 pmol daily, the values will be 30-221 pmol (10-73 ng) with a mean of 113 pmol (37-4 ng),
Free DOC excretion in essential hypertension. Fourteen patients with essential hypertension, without evidence of metabolic disturbance, have been studied. Urinary DOC excretion rates have ranged from 28 to 144 pmol daily (9'5--47·7 ng), the mean value for the group being 87 pmol (28'8 ng) daily. It is apparent that there is no significant difference from the normal in such subjects (P> 0'1).
Free DOC excretion in Cushing's syndrome. Of twelve patients with active Cushing's syndrome due to bilateral adrenal hyperplasia, ten showed normal urinary free DOC excretion, the range being from 26 to 197 pmol daily (8'7-65 ng), with a mean of 116 pmol (310 ng). The two remaining patients showed daily excretion of 350 pmol (115'7 ng) and 542 pmol (179 ng) respectively. Raised cortisol production is therefore not usually accompanied by increased DOC excretion.
Free DOC excretion in hypokalaemia. Table 4 lists nine patients in whom a marked tendency to hypokalaemia was observed. Two of these (Da and Br) were normotensive and the remainder hypertensive. Eight showed free urinary DOC excretion rates above the upper normal limit. Three (Cu, Br and Sm) also had increased aldosterone excretion, but in the remainder this was normal. The urinary DOC excretion rates have ranged from 25 to 2300% above the upper limit of normal.
There was no correlation between the behaviour of the two hormones in this small series.
Other states of increased excretion of deoxycorticosterone
In two hypertensive subjects temporarily raised DOC excretion has been observed immediately after acute stress, in one excretion was 1940 pmol (640 ng) daily after surgical operation, and in the other 430 pmol (142 ng daily) after a vertebral artery thrombosis. DOC excretion returned to normal after the subsidence of the stress.
DOC excretion is also well recognized to be greatly enhanced during administration of metyrapone, a drug which inhibits l I-hydroxylation. Examples of this are shown in Table 3 (samples 9 and 10). The specificity of this antiserum is high, but is not alone adequate to provide identification of free DOC in urine. Some cross-reaction occurs with progesterone, corticosterone, 18-hydroxy deoxycorticosterone and with at least one unidentified substance present in urine. Adequate removal of interfering compounds must therefore be dependent on the chromatography. The above-mentioned steroids are all effectively removed by the B3 chromatogram, the RF of each being sufficiently different to avoid overlap with the DOC zone. But an unidentified contaminant has been detected, running sufficiently close to the DOC zone in this system to cause some overlap. A second stage of chromatography has therefore been necessary as a routine. The effective removal of this and of other possible contaminants has been demonstrated by the constancy of its specific radioactivity when the component of the DOC zone is run on successive and different solvent systems. The data in Table 3 show that this has been achieved within the experimental error of the assays. The estimated DOC excretion rates are derived directly from the specific radioactivities of the DOC zone eluates. Since the component of normal urine estimated by the specific antiserum runs at the same rate as authentic DOC in three different chromatographic systems, and like DOC loses its ability to react to the antiserum after acetylation it is presumed to be DOC. The estimated normal excretion is from 41 to 232 pmol (13·7-76'7 ng) daily with a mean of 124 pmol (41 ng). The fact that DOC excretion rates have been found to be within the normal range in ten of the twelve patients with Cushing's syndrome due to adrenal hyperplasia we have studied is in agreement with the report of Crane & Harris (1966) , who found normal to low DOC secretion rates and normal TH-DOC excretion in all six cases they studied. Biglieri et al. (1968) also found normal DOC secretion in three of four patients with Cushing's syndrome due to hyperplasia or adenoma.
These results indicate that sustained overactivity of the adrenal zona fasciculata does not necessarily lead to an increased DOC excretion to accompany the enhanced cortisol production. But circumstances as yet unidentified may apparently lead to raised DOC production in Cushing's syndrome, for two of our patients showed raised excretion rates and Nolten, Vecsei, Kohler, Purjesz & Wolff (1968) found the DOC secretion rate to be raised in five of six cases of 'hypercorticism' studied by them, and Oddie et al. (1972) found raised plasma DOC in all four of their cases of adrenal hyperplasia.
In all fourteen of our cases of essential hypertension without evidence of metabolic disturbance DOC excretion has been found to be within normal limits, the mean for the group not differing significantly from the normal mean (P>O·I). These results are in conformity with the finding of Biglieri et al. (1968) and of Woods, Liddle, Staut, Michelakis & Brill (1969) , both of which groups found normal DOC secretion rates in all their sixteen cases of essential hypertension. Oddie et al. (1972) found no significant rise in mean plasma DOC in essential hypertension, though three of fourteen cases were above the normal range.
In sharp contrast to this background of undisturbed DOC production in essential hypertension, and in adrenal hyperplasia stand the nine cases associated with hypokalaemia, eight of which had raised DOC excretion.
Of the hypertensive cases one (Cu) had a confirmed aldosterone-producing tumour, and DOC excretion in this patient returned to normal after removal of the adenoma. Elevated DOC production in such patients is well documented. Biglieri et al. (1968) found secretion raised in four of seventeen cases, and Nolten et al. (1968) found it raised in seven of twelve cases examined by them.
Another hypertensive patient (Ep) had a pancreatic carcinoma with associated ectopic ACTH syndrome. In this condition also raised DOC secretion has been recognized, for Biglieri et al. (1968) found increases in all their three cases and Schambelan, Slaton & Biglieri (1971) found elevated DOC secretion in six further cases.
In four (Ri, Go, Ly and Fi) of our remaining hypertensive patients the diagnosis was unconfirmed, but was believed to be a mild zona glomerulosa hyperplasia of the type described in much more severe form by Biglieri (1965) . The last hypertensive patient (Sm) is still under observation, the presence of an aldosterone-producing tumour being suspected.
In the normotensive patient (Br) the hypokalaemia was due to excessive diuretic addiction. The moderate increase in DOC excretion was accompanied by an elevated aldosterone excretion which was due to sustained sodium loss from the persistent diuretic action. In the other normotensive patient (Da), the hypokalaemia was due to purgative addiction.
The close association of raised DOC excretion with a tendency to hypokalaemia is impressive, and complements the findings of Brown et al. (1972) of raised plasma DOC concentrations in all the hypertensive subjects with hypokalaemia examined by them. But the association is evidently not confined to hypertensive persons.
Excessive DOC production is not an inevitable result of enhanced adrenocortical activity, nor is it a usual result of essential hypertension. The reason for its occurrence is not yet clearly defined. But the over-production indicates an abnormal metabolism in the adrenal cortex, either in the zona fasciculata or in the zona glomerulosa. Its detection in a hypertensive subject may therefore provide a clue to a possible aetiological factor.
Three possible methods of detection of DOC over-production are available. The first, the measurement of DOC secretion rate, determined from the specific radioactivity of the excreted metabolite tetrahydrodeoxycorticosterone after injection of labelled DOC, calls for an exacting technique which, in a recently published method, involves six to eight successive stages of chromatography (Seth, Nowaczynski, Kuchel, Mancheno-Rico & Genest, 1972) . The second method, detection of raised plasma DOC concentrations, has hitherto been almost as difficult (Oddie et al., 1972) but is now relatively simplified by the radioimmunoassay technique of Arnold & James (1971) . The antiserum used in the second method provides the third method, since we show here that it is capable of detecting DOC in normal human urine and of readily revealing elevated DOC excretion rates in hypokalaemic subjects.
The relative advantages of urine over plasma DOC assays for the detection of raised DOC production have yet to be determined. Urine has the advantage of providing an integrated mean of variations in production over a prolonged period, whereas a plasma value expresses the situation at a moment in time. Urinary free cortisol has already proved a valuable and sensitive index of raised cortisol production (Cope & Black, 1959; Burke & Beardwell, 1973) and urinary free DOC may be an index of similar sensitivity. It is of interest that our mean DOC excretion suggests a 24 h renal DOC clearance of about 700 ml if a mean plasma DOC of 182 pmol(1 (6 ng(1oo ml) is assumed (Oddie et al., 1972) . This may be compared with a renal cortisol clearance of about 500 ml daily.
For clinical screening purposes one stage of paper chromatography should usually suffice, the error introduced by omitting the second chromatography rarely exceeding 15%.
An elevated DOC production imples abnormality of adrenal cortical function. Such a rise does not necessarily correlate with the intensity of either cortisol or aldosterone production. It must be regarded as a separate indicator of adrenal cortical abnormality.
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